Interleukin-1β (IL-1β) is a pro-inflammatory cytokine that plays a crucial role in the body’s immune response. It is produced primarily by activated monocytes and macrophages. IL-1β is involved in various cellular activities, including cell proliferation, differentiation, and apoptosis. It is a key mediator in the inflammatory response and is implicated in a variety of diseases, including autoimmune disorders, infectious diseases, and cancer.
IL-1β is synthesized as a 31 kDa precursor protein. To become active, this precursor must be cleaved by caspase-1 between Asp116 and Ala117, resulting in a 17 kDa mature form . The detection of this mature form is often used as an indicator of caspase-1 activity.
Mouse anti-human IL-1β antibodies are monoclonal antibodies developed in mice that specifically target human IL-1β. These antibodies are widely used in research and clinical applications to study the role of IL-1β in various diseases and to develop therapeutic strategies.
Mouse anti-human IL-1β antibodies can be used in several scientific applications, including:
Mouse anti-human IL-1β antibodies are designed to specifically bind to human IL-1β. They do not cross-react with IL-1β from other species, such as mouse, rat, rabbit, or macaques . This specificity is crucial for accurate detection and quantification of human IL-1β in various experimental settings.
There are different types of mouse anti-human IL-1β antibodies available, including: